Abdominal Aortic Aneurysm: What About Screening?

Title:Abdominal Aortic Aneurysm: What About Screening?

Volume: 21 Issue: 28

Author(s): Francois Saucy, Sebastien Déglise, Thomas Holzer, Lukas Briner, Marie Benezit, Charline Delay, Caroline Kazandjian and Jean-Marc Corpataux

Affiliation:

Keywords: Abdominal aortic aneurysm, screening, risk factors, ultrasonography.

Abstract: The prevalence of abdominal aortic aneurysm (AAA) in general population is 4-9% with a high mortality rate when ruptured. Therefore, screening programs were developed in many countries to detect small and large AAA in selected patients. Indeed, prevalence of AAA increases in patients over 65 years old with cigarette smoking history. This paper reviews recent literature related to AAA screening focusing on epidemiology, screening tests and evidence based medicine to highlight not only advantages but also disadvantages of screening programs among population.

Cite this article as:

Saucy Francois, Déglise Sebastien, Holzer Thomas, Briner Lukas, Benezit Marie, Delay Charline, Kazandjian Caroline and Corpataux Jean-Marc, Abdominal Aortic Aneurysm: What About Screening?, Current Pharmaceutical Design 2015; 21 (28) . https://dx.doi.org/10.2174/1381612821666150826095148